AskBio has announced a strategic collaboration with Belief BioMed to explore liver-targeted gene therapies. The partnership ...

Italian biotech Genespire has secured 46.6 million euros ($52 million) in Series B financing to advance its gene therapy ...

Eli Lilly's Kisunla has been approved in Japan for early symptomatic Alzheimer's disease, following its US approval in July ...

US biotech 2seventy bio and partner Bristol Myers Squibb today revealed that they will discontinue enrollment in its ongoing ...

Amgen yesterday revealed that Tepezza (teprotumumab [genetical recombination]) has been approved for the treatment of active ...

Centivo has raised $75 million in equity and debt financing to expand its affordable healthcare plans for self-funded ...

President Biden has pledged $500 million and up to one million doses of mpox vaccines to support Central and Eastern Africa ...

Bluebird bio has announced a restructuring to cut costs by 20% and achieve quarterly cash flow break-even by late 2025. The ...

Swiss contract development and manufacturing organization (CDMO) Lonza (VTX: LONN) has signed a long-term commercial supply ...

French drugmaker Mitem Pharma, which says it is dedicated to Medicines of Major Therapeutic Interest (MITM), has the worldwide acquisition of Desferal (deferoxamine), a major MITM in hematology, from ...

Wave Life Sciences has announced positive interim data from the ongoing Phase II FORWARD-53 study of WVE-N531, which is an ...

Belgian drugmaker UCB (Euronext: UCB) has announced the presentation of new four-year data in patients with moderate to ...